Publication date: 17 September 2026 Source: Molecular Therapy Oncology, Volume 34, Issue 3 Author(s): Xin Zhou, Gregory H. Bird, Mu Yu, Jian-Liang Li, Xzaviar K. Solone, Michael C. Chung, Juan Guan, Loren D. Walensky, Lizi Wu
Targeting LKB1-inactivated lung cancers with a stapled peptide inhibitor of the CRTC-CREB pathway. // Molecular Therapy: Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2950329926002079?dgcid=rss_sd_all
Targeting LKB1-inactivated lung cancers with a stapled peptide inhibitor of the CRTC-CREB pathway. Molecular Therapy: Oncology. https://www.sciencedirect.com/science/article/pii/S2950329926002079?dgcid=rss_sd_all
“Targeting LKB1-inactivated lung cancers with a stapled peptide inhibitor of the CRTC-CREB pathway.” Molecular Therapy: Oncology.
@article{article59428,
title = {Targeting LKB1-inactivated lung cancers with a stapled peptide inhibitor of the CRTC-CREB pathway},
journal = {Molecular Therapy: Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2950329926002079?dgcid=rss_sd_all}
}